BIIB vs HPE · P/E 21, rev $9.89B vs P/E 20, rev $32.19B
Biogen Inc (BIIB) versus Hewlett Packard Enterprise Co (HPE) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Not investment advice. Open the BIIB and HPE stock pages for the full models.
Not investment advice.